Keep God Weird

358 of 413 drug patent of invention applications for the disease in Republic Of India are from top multinationals.

The recent legal changes by reversal suffered by transnational major league Novartis and Roche over patents of invention for malignant neoplastic disease medical specialty could be the tip of a immense iceberg.

A city-based policy research grouping have got establish that transnational drug houses have filed over 350 patent of invention applications for drugs used in malignant neoplastic disease treatment.

An analysis of drug company patent of invention of invention of invention applications pending with the patent business office by the group, which did not wish to be identified, have set the figure of malignant neoplastic disease drug patent applications at 413. Of these, 358 came from top multinationals like Novartis, Aventis, Bristol Myers Squibb, Pfizer, Boehringer, Roche and Abbot.

The haste for patents of invention on malignant neoplastic disease medical specialty can be explained by the possible of the Rs 1,200 crore Indian market.

With nearly 2.5 million patients, malignant neoplastic disease is one of the 10 leading causes of decease in India. Data beginnings from the National Cancer Register Program show that over 700,000 new lawsuits and 300,000 deceases happen annually owed to cancer.

However, not all 413 applications will go through muster with the patent of invention of invention office, a patent expert warned. Republic Of India makes not give patents of invention on drugs patented elsewhere before 1995.

The patent of invention of invention expert said only two drugs in the listing of applicantions were granted patent in the United States after 1995. Most applications, people involved in the research said, are for derived functions or minor alterations of medical specialties that are not eligible for patents.

"Our analysis shows that most of these applications make not measure up for patents of invention in India. Therefore, the patent of invention testers necessitate to be very careful while scrutinising them," the research worker who takes the survey said.

The concerns of the research workers addition more significance in the background of the Old Delhi High Court's interim order allowing Cipla to marketplace its anti-cancer drug, Erlontib, though Roche was granted a patent of invention on it. Tarceva is the first and only malignant neoplastic disease medical specialty to acquire a merchandise patent of invention of invention (the patent that denies the entry of low-cost copycat versions of the medicine) in India.

The other malignant neoplastic disease medicine, Glivec, from Novartis, was denied a patent of invention of invention in the state because the patent business office felt that the medical specialty was an improvement of a known matter and hence non-patentable.

Novartis have appealed against the patent of invention denial to the Intellectual Place Appellate Board (IPAB). The high-profile patent of invention warfare have been considered a diagnostic test lawsuit in pre-grant resistance of patent applications.